Company
Who we are
Axxam is an innovative research and discovery organization providing early discovery services across the life sciences industry. Since our founding in 2001, we have been committed to pioneering creative and visionary approaches in the pharmaceutical and biotechnology fields, guided by the rigor of science, a spark of genius, and a dedication to improving human health worldwide.
Our passion for discovery extends into other fields of research, including agrochemicals. Through our research platform AXXSense, we contribute to the development of novel bioactive compounds that enhance products in the food & beverage, flavors & fragrances, pet food, cosmetics, and perfume industries — ultimately improving multiple aspects of daily life.
Defined by scientific excellence and quality, we are a high-tech company that integrates state-of-the-art advancements — including artificial intelligence and machine learning for target identification and compound library design — into our work. We are also deeply committed to corporate social responsibility, ensuring that our research and business practices contribute to a more sustainable and ethical future.
Mission
Harness biology, empower discovery
Our mission is to support clients and partners transforming ideas into actionable discoveries and translating innovative biology into bioactive molecules. We strive to push the boundaries of science to solve tough challenges and make a meaningful difference in people’s lives.
Our ultimate goal is to lead the way in life sciences and create solutions that redefine what is possible, and inspiring a healthier, more sustainable world.
Our core business
As experts in early-stage drug discovery, we offer high-quality, customized solutions across multiple disciplines to help our clients generate valuable leads.
We design and develop advanced cell-free and cell-based in vitro assays and conduct high-throughput screening campaigns using our proprietary synthetic and natural compound collections or client-provided libraries to identify promising hit compounds. Our services extend beyond hit identification to hit-to-lead programs, ensuring the most promising leads move to the next phases of development.
Defined by scientific excellence, innovation, and quality, Axxam integrates breakthrough tools, such as our pioneering organellar electrophysiology platform, iPSC derived models, optogenetics, high-content screening, etc. into every step of the process. As we continue to evolve, we are embracing transformative advancements like artificial intelligence to remain at the forefront of scientific innovation.
Research collaborators: delivering expertise and intellectual value
As a contract research organization (CRO), we go beyond simply addressing client needs by providing a true and meaningful intellectual contribution to every project we undertake.
A method that evolves with every challenge
Our approach is rooted in problem-solving — pure and precise — constantly refined and enriched by the expertise of our team of scientists. We design customized methodologies to address each client’s unique challenges, providing not just solutions but innovative pathways to success.
Where we are
Axxam has offices in two highly popular and dynamic Italian cities: our headquarters and biology/screening laboratories are located at OpenZone Campus in Bresso, a small city on the outskirts of Milan, the heart of the economy, design and scientific research in Italy, while our medicinal chemistry laboratories are located at the Novartis Torre Campus in Torre Annunziata, very close to Naples, the capital of classical Mediterranean beauty.
Our subsidiary Axxam Inc. is located at the Cambridge Innovation Center (CIC) in Kendall Square, Cambridge (USA).
We have business offices at Symbion in Copenhagen (Denmark) and the Switzerland Innovation Park Basel Area AG in Basel (Switzerland).